<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl9960</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-9960</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Перспективы применения интраназально вводимого инсулина для коррекции метаболических и гормональных нарушений при сахарном диабете и метаболическом синдроме</article-title><trans-title-group xml:lang="en"><trans-title>Perspectives of application of intranasally administered insulin for correction of metabolic and hormonal disorders in diabetes mellitus and metabolic syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4293-3162</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шпаков</surname><given-names>Александр Олегович</given-names></name><name name-style="western" xml:lang="en"><surname>Shpakov</surname><given-names>Alexander O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.б.н.</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">alex_shpakov@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6555-9540</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Деркач</surname><given-names>Кира Викторовна</given-names></name><name name-style="western" xml:lang="en"><surname>Derkach</surname><given-names>Kira V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н.</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">derkatch_kira@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3973-7638</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суркова</surname><given-names>Елена Викторовна</given-names></name><name name-style="western" xml:lang="en"><surname>Surkova</surname><given-names>Elena V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н.</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">elenasurkova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1584-5690</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беспалов</surname><given-names>Алексей Игоревич</given-names></name><name name-style="western" xml:lang="en"><surname>Bespalov</surname><given-names>Alexey I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аспирант отделения терапии диабета</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">finger1ess@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУН «Институт эволюционной физиологии и биохимии им. И.М. Сеченова» РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov Institute of Evolutionary Physiology and Biochemistry of Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>11</month><year>2019</year></pub-date><volume>65</volume><issue>5</issue><fpage>389</fpage><lpage>395</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шпаков А.О., Деркач К.В., Суркова Е.В., Беспалов А.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Шпаков А.О., Деркач К.В., Суркова Е.В., Беспалов А.И.</copyright-holder><copyright-holder xml:lang="en">Shpakov A.O., Derkach K.V., Surkova E.V., Bespalov A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/9960">https://www.probl-endojournals.ru/jour/article/view/9960</self-uri><abstract><p>В последние годы широко изучается возможность применения интраназально вводимого инсулина для лечения болезни Альцгеймера и других когнитивных расстройств. В то же время практически не исследуется возможность его применения в рамках терапии сахарного диабета, что во многом связано с недостаточной изученностью молекулярных механизмов его действия на гормональный и метаболический статусы организма. В обзоре обсуждаются данные литературы и результаты собственных исследований о роли инсулина в центральной регуляции энергетического гомеостаза, а также об опыте применения интраназально вводимого инсулина для коррекции нарушений пищевого поведения и метаболических и гормональных дисфункций, развивающихся в условиях экспериментального сахарного диабета и метаболического синдрома. В исследованиях с участием здоровых добровольцев были показаны различные эффекты интраназально вводимого инсулина, в том числе влияние на когнитивные функции, пищевое поведение и снижение массы тела, а также обнаружена гендерная специфичность его действия. В ходе многочисленных исследований интраназально вводимого инсулина на животных моделях сахарного диабета были показаны не только стабилизация углеводного гомеостаза, но и положительное действие в виде восстановления функциональной активности инсулиновых сигнальных путей в гипоталамусе и других отделах мозга. Нами представлены и проанализированы данные о системных эффектах интраназально вводимого инсулина у грызунов с экспериментальными моделями сахарного диабета, а также у здоровых индивидуумов.</p></abstract><trans-abstract xml:lang="en"><p>In recent years, the possibility of using intranasally administered insulin to treat Alzheimer’s disease and other cognitive disorders has been widely studied. At the same time, the possibility of its use in the treatment of diabetes mellitus is practically not investigated, which is due to the insufficient study of the molecular mechanisms of its action on the hormonal and metabolic status of the organism. The review discusses literature data and the results of our own research on the role of insulin in the central regulation of energy homeostasis, as well as on the experience of using intranasally administered insulin to correct eating disorders and metabolic and hormonal dysfunctions developing under conditions of experimental diabetes mellitus and metabolic syndrome. In studies involving healthy volunteers, various effects of intranasally administered insulin were shown, including effects on cognitive function, eating behavior and weight loss, and the gender specificity of its action was found. In the course of numerous studies of intranasally administered insulin in animal models of diabetes mellitus, not only stabilization of carbohydrate homeostasis was shown, but also a positive effect in the form of restoration of the functional activity of insulin signaling pathways in the hypothalamus and other parts of the brain. We have presented and analyzed data on the systemic effects of intranasally administered insulin in rodents with experimental models of diabetes mellitus, as well as in healthy individuals.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инсулин</kwd><kwd>интраназальное введение</kwd><kwd>сахарный диабет</kwd><kwd>метаболический синдром</kwd><kwd>мозг</kwd><kwd>инсулинорезистентность</kwd><kwd>энергетический обмен</kwd><kwd>тиреоидная система</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Insulin</kwd><kwd>intranasal administration</kwd><kwd>diabetes mellitus</kwd><kwd>metabolic syndrome</kwd><kwd>brain</kwd><kwd>insulin resistance</kwd><kwd>energy metabolism</kwd><kwd>thyroid system</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Поисково-аналитическая работа по подготовке рукописи проведена в рамках исполнения государственного задания ФАНО России №АААА-А18-118012290427-7.</funding-statement><funding-statement xml:lang="en">Search and analytical work on the preparation of the manuscript was carried out within the framework of the execution of the state assignment of FANO of Russia № AAAA-A18-118012290427-7.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov AO, Derkach KV. Gormonal’nye sistemy mozga i sakharnyy diabet 2-go tipa. Saint-Petersburg: Izdatel’stvo Politekhnicheskogo universiteta; 2015.</mixed-citation><mixed-citation xml:lang="en">Shpakov AO, Derkach KV. Gormonal’nye sistemy mozga i sakharnyy diabet 2-go tipa. Saint-Petersburg: Izdatel’stvo Politekhnicheskogo universiteta; 2015.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gizurarson S, Bechgaard E. Intranasal administration of insulin to humans. Diabetes Res Clin Pract. 1991;12(2):71-84. doi: https://doi.org/10.1016/0168-8227(91)90083-p</mixed-citation><mixed-citation xml:lang="en">Gizurarson S, Bechgaard E. Intranasal administration of insulin to humans. Diabetes Res Clin Pract. 1991;12(2):71-84. doi: https://doi.org/10.1016/0168-8227(91)90083-p</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hirai S, Ikenaga T, Matsuzawa T. Nasal Absorption of Insulin in Dogs. Diabetes. 1978;27(3):296-299 doi: https://doi.org/10.2337/diab.27.3.296</mixed-citation><mixed-citation xml:lang="en">Hirai S, Ikenaga T, Matsuzawa T. Nasal Absorption of Insulin in Dogs. Diabetes. 1978;27(3):296-299 doi: https://doi.org/10.2337/diab.27.3.296</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Frauman A, Buchanan R, Jerumus G, Louis W. Intranasal insulin (INI) treatment of type I diabetes: clinical and immunologic effects using two different absorption enhancing adjuvants. Diabetes Res Clin Pract. 1988;5(Suppl 1):S162.</mixed-citation><mixed-citation xml:lang="en">Frauman A, Buchanan R, Jerumus G, Louis W. Intranasal insulin (INI) treatment of type I diabetes: clinical and immunologic effects using two different absorption enhancing adjuvants. Diabetes Res Clin Pract. 1988;5(Suppl 1):S162.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Derkach KV, Ivantsov AO, Chistyakova OV, et al. Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome. Biull Eksp Biol Med. 2017;163(2):144-149.</mixed-citation><mixed-citation xml:lang="en">Derkach KV, Ivantsov AO, Chistyakova OV, et al. Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome. Biull Eksp Biol Med. 2017;163(2):144-149.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29-38. doi: https://doi.org/10.1001/archneurol.2011.233</mixed-citation><mixed-citation xml:lang="en">Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29-38. doi: https://doi.org/10.1001/archneurol.2011.233</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Baskin D. Insulin In The Brain. Annu Rev Physiol. 1987;49(1):335-347. doi: https://doi.org/10.1146/annurev.ph.49.030187.002003</mixed-citation><mixed-citation xml:lang="en">Baskin D. Insulin In The Brain. Annu Rev Physiol. 1987;49(1):335-347. doi: https://doi.org/10.1146/annurev.ph.49.030187.002003</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Porte Jr D, Seeley RJ, Woods SC, et al. Obesity, diabetes and the central nervous system. Diabetologia. 1998;41(8):863-881. doi: https://doi.org/10.1007/s001250051002</mixed-citation><mixed-citation xml:lang="en">Porte Jr D, Seeley RJ, Woods SC, et al. Obesity, diabetes and the central nervous system. Diabetologia. 1998;41(8):863-881. doi: https://doi.org/10.1007/s001250051002</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Med. 2002;8(12):1376-1382. doi: https://doi.org/10.1038/nm1202-798</mixed-citation><mixed-citation xml:lang="en">Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Med. 2002;8(12):1376-1382. doi: https://doi.org/10.1038/nm1202-798</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hallschmid M, Benedict C, Schultes B, et al. Intranasal Insulin Reduces Body Fat in Men but not in Women. Diabetes. 2004;53(11): 3024-3029. doi: https://doi.org/10.2337/diabetes.53.11.3024</mixed-citation><mixed-citation xml:lang="en">Hallschmid M, Benedict C, Schultes B, et al. Intranasal Insulin Reduces Body Fat in Men but not in Women. Diabetes. 2004;53(11): 3024-3029. doi: https://doi.org/10.2337/diabetes.53.11.3024</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nature Neuroscience. 2002;5(6):514-516. doi: https://doi.org/10.1038/nn0602-849</mixed-citation><mixed-citation xml:lang="en">Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nature Neuroscience. 2002;5(6):514-516. doi: https://doi.org/10.1038/nn0602-849</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Clegg DJ, Riedy CA, Smith KAB, et al. Differential Sensitivity to Central Leptin and Insulin in Male and Female Rats. Diabetes. 2003;52(3):682-687. doi: https://doi.org/10.2337/diabetes.52.3.682</mixed-citation><mixed-citation xml:lang="en">Clegg DJ, Riedy CA, Smith KAB, et al. Differential Sensitivity to Central Leptin and Insulin in Male and Female Rats. Diabetes. 2003;52(3):682-687. doi: https://doi.org/10.2337/diabetes.52.3.682</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hallschmid M, Benedict C, Schultes B, et al. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes (Lond). 2008;32(2):275-282. doi: https://doi.org/10.1038/sj.ijo.0803722</mixed-citation><mixed-citation xml:lang="en">Hallschmid M, Benedict C, Schultes B, et al. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes (Lond). 2008;32(2):275-282. doi: https://doi.org/10.1038/sj.ijo.0803722</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jauch-Chara K, Friedrich A, Rezmer M, et al. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. Diabetes. 2012;61(9):2261-2268. doi: https://doi.org/10.2337/db12-0025</mixed-citation><mixed-citation xml:lang="en">Jauch-Chara K, Friedrich A, Rezmer M, et al. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. Diabetes. 2012;61(9):2261-2268. doi: https://doi.org/10.2337/db12-0025</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kenny PJ. Reward mechanisms in obesity: new insights and future directions. Neuron. 2011;69(4):664-679. doi: https://doi.org/10.1016/j.neuron.2011.02.016</mixed-citation><mixed-citation xml:lang="en">Kenny PJ. Reward mechanisms in obesity: new insights and future directions. Neuron. 2011;69(4):664-679. doi: https://doi.org/10.1016/j.neuron.2011.02.016</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15(1):37-46. doi: https://doi.org/10.1016/j.tics.2010.11.001</mixed-citation><mixed-citation xml:lang="en">Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15(1):37-46. doi: https://doi.org/10.1016/j.tics.2010.11.001</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Appelhans BM. Neurobehavioral inhibition of reward-driven feeding: implications for dieting and obesity. Obesity (Silver Spring). 2009;17(4):640-647. doi: https://doi.org/10.1038/oby.2008.638</mixed-citation><mixed-citation xml:lang="en">Appelhans BM. Neurobehavioral inhibition of reward-driven feeding: implications for dieting and obesity. Obesity (Silver Spring). 2009;17(4):640-647. doi: https://doi.org/10.1038/oby.2008.638</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lathe R. Hormones and the hippocampus. J Endocrinol. 2001; 169(2):205-231. doi: https://doi.org/10.1677/joe.0.1690205</mixed-citation><mixed-citation xml:lang="en">Lathe R. Hormones and the hippocampus. J Endocrinol. 2001; 169(2):205-231. doi: https://doi.org/10.1677/joe.0.1690205</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Figlewicz DP, Szot P, Chavez M, et al. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 1994;644(2):331-334. doi: https://doi.org/10.1016/0006-8993(94)91698-5</mixed-citation><mixed-citation xml:lang="en">Figlewicz DP, Szot P, Chavez M, et al. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 1994;644(2):331-334. doi: https://doi.org/10.1016/0006-8993(94)91698-5</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Guthoff M, Grichisch Y, Canova C, et al. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab. 2010;95(2):748-755. doi: https://doi.org/10.1210/jc.2009-1677</mixed-citation><mixed-citation xml:lang="en">Guthoff M, Grichisch Y, Canova C, et al. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab. 2010;95(2):748-755. doi: https://doi.org/10.1210/jc.2009-1677</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes. 2006;55(4):978-987. doi: https://doi.org/10.2337/diabetes.55.04.06.db05-1339</mixed-citation><mixed-citation xml:lang="en">Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes. 2006;55(4):978-987. doi: https://doi.org/10.2337/diabetes.55.04.06.db05-1339</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Krug R, Benedict C, Born J, Hallschmid M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J Clin Endocrinol Metab. 2010;95(12):E468-472. doi: https://doi.org/10.1210/jc.2010-0744</mixed-citation><mixed-citation xml:lang="en">Krug R, Benedict C, Born J, Hallschmid M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J Clin Endocrinol Metab. 2010;95(12):E468-472. doi: https://doi.org/10.1210/jc.2010-0744</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hallschmid M, Higgs S, Thienel M, et al. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes. 2012;61(4):782-789. doi: https://doi.org/10.2337/db11-1390.</mixed-citation><mixed-citation xml:lang="en">Hallschmid M, Higgs S, Thienel M, et al. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes. 2012;61(4):782-789. doi: https://doi.org/10.2337/db11-1390.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Koch L, Wunderlich FT, Seibler J, et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118(6):2132-2147. doi: https://doi.org/10.1172/JCI31073</mixed-citation><mixed-citation xml:lang="en">Koch L, Wunderlich FT, Seibler J, et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118(6):2132-2147. doi: https://doi.org/10.1172/JCI31073</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Heni M, Wagner R, Kullmann S, et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014;63(12):4083-4088. doi: https://doi.org/10.2337/db14-0477</mixed-citation><mixed-citation xml:lang="en">Heni M, Wagner R, Kullmann S, et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014;63(12):4083-4088. doi: https://doi.org/10.2337/db14-0477</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Dash S, Xiao C, Morgantini C, et al. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations. Diabetes. 2015;64(3):766-774. doi: https://doi.org/10.2337/db14-0685</mixed-citation><mixed-citation xml:lang="en">Dash S, Xiao C, Morgantini C, et al. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations. Diabetes. 2015;64(3):766-774. doi: https://doi.org/10.2337/db14-0685</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Chen M, Woods SC, Porte D. Effect of Cerebral Intraventricular Insulin on Pancreatic Insulin Secretion in the Dog. Diabetes. 1975;24(10):910-914. doi: https://doi.org/10.2337/diab.24.10.910</mixed-citation><mixed-citation xml:lang="en">Chen M, Woods SC, Porte D. Effect of Cerebral Intraventricular Insulin on Pancreatic Insulin Secretion in the Dog. Diabetes. 1975;24(10):910-914. doi: https://doi.org/10.2337/diab.24.10.910</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 2012;16(4):500-510. doi: https://doi.org/10.1016/j.cmet.2012.09.005</mixed-citation><mixed-citation xml:lang="en">Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 2012;16(4):500-510. doi: https://doi.org/10.1016/j.cmet.2012.09.005</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Chaiken RL, Moses AC, Silver RD, et al. The Prolonged Hypoglycemic Effect Of An Insulin-Adjuvant Nasal Spray In Diabetes Is Secondary To Prolonged Suppression Of Hepatic Glucose Output. Clin Res. 1985;33(2):A426.</mixed-citation><mixed-citation xml:lang="en">Chaiken RL, Moses AC, Silver RD, et al. The Prolonged Hypoglycemic Effect Of An Insulin-Adjuvant Nasal Spray In Diabetes Is Secondary To Prolonged Suppression Of Hepatic Glucose Output. Clin Res. 1985;33(2):A426.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov AO, Moyseyuk IV, Chistyakova OV, et al. Treatment with intranasal insulin and serotonin restores the sensitivity of adenylyl cyclase to hormone in the brain of rats with long-term neonatal diabetes mellitus. Biulletenʹ FTSSKE im. V.A. Almazova. 2013;(1):21-27.</mixed-citation><mixed-citation xml:lang="en">Shpakov AO, Moyseyuk IV, Chistyakova OV, et al. Treatment with intranasal insulin and serotonin restores the sensitivity of adenylyl cyclase to hormone in the brain of rats with long-term neonatal diabetes mellitus. Biulletenʹ FTSSKE im. V.A. Almazova. 2013;(1):21-27.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov A, Chistyakova O, Derkach K, et al. Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes. Open Life Sci. 2012;7(1). doi: https://doi.org/10.2478/s11535-011-0089-6</mixed-citation><mixed-citation xml:lang="en">Shpakov A, Chistyakova O, Derkach K, et al. Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes. Open Life Sci. 2012;7(1). doi: https://doi.org/10.2478/s11535-011-0089-6</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov AO, Derkach KV, Chistyakova OV, et al. Effect of intranasal insulin and serotonin on functional activity of the adenylyl cyclase system in myocardium, ovary, and uterus of rats with prolonged neonatal model of diabetes mellitus. Zh Evol Biokhim Fiziol. 2013;49(2):118-127.</mixed-citation><mixed-citation xml:lang="en">Shpakov AO, Derkach KV, Chistyakova OV, et al. Effect of intranasal insulin and serotonin on functional activity of the adenylyl cyclase system in myocardium, ovary, and uterus of rats with prolonged neonatal model of diabetes mellitus. Zh Evol Biokhim Fiziol. 2013;49(2):118-127.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Sukhov IB, Derkach KV, Chistyakova OV, et al. Functional state of hypothalamic signaling systems in rats with type 2 diabetes mellitus treated with intranasal insulin. Zh Evol Biokhim Fiziol. 2016;52(3):184-194.</mixed-citation><mixed-citation xml:lang="en">Sukhov IB, Derkach KV, Chistyakova OV, et al. Functional state of hypothalamic signaling systems in rats with type 2 diabetes mellitus treated with intranasal insulin. Zh Evol Biokhim Fiziol. 2016;52(3):184-194.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznetsova LA, Plesneva SA, Sharova TS, et al. Attenuation of inhibitory influence of hormones on adenylyl cyclase systems in the myocardium and brain of obese and type 2 diabetic rats as affected by the intranasal insulin treatment. Zh Evol Biokhim Fiziol. 2014;50(5):349-357.</mixed-citation><mixed-citation xml:lang="en">Kuznetsova LA, Plesneva SA, Sharova TS, et al. Attenuation of inhibitory influence of hormones on adenylyl cyclase systems in the myocardium and brain of obese and type 2 diabetic rats as affected by the intranasal insulin treatment. Zh Evol Biokhim Fiziol. 2014;50(5):349-357.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznetsova LA, Sharova TS, Pertseva MN, Shpakov AO. Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration. Zh Evol Biokhim Fiziol. 2015;51(3):170-180.</mixed-citation><mixed-citation xml:lang="en">Kuznetsova LA, Sharova TS, Pertseva MN, Shpakov AO. Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration. Zh Evol Biokhim Fiziol. 2015;51(3):170-180.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov AO, Chistyakova OV, Derkach KV, et al. Activity of receptor guanylyl cyclases in rats with neonatal streptozotocin diabetes and effect of intranasal administration of insulin and serotonin. Cell and Tissue Biology. 2011;53(7):591-599.</mixed-citation><mixed-citation xml:lang="en">Shpakov AO, Chistyakova OV, Derkach KV, et al. Activity of receptor guanylyl cyclases in rats with neonatal streptozotocin diabetes and effect of intranasal administration of insulin and serotonin. Cell and Tissue Biology. 2011;53(7):591-599.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Chistyakova OV, Sukhov IB, Shipilov VN, et al. Vliyanie intranazal’nogo vvedeniya insulina i serotonina na kognitivnye protsessy u krys s eksperimental’nym sakharnym diabetom 2-go tipa. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2010;8(1):M75</mixed-citation><mixed-citation xml:lang="en">Chistyakova OV, Sukhov IB, Shipilov VN, et al. Vliyanie intranazal’nogo vvedeniya insulina i serotonina na kognitivnye protsessy u krys s eksperimental’nym sakharnym diabetom 2-go tipa. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2010;8(1):M75</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznetsova LA, Derkach KV, Sharova TS, et al. The activity of no-synthases in the brain, myocardium and skeletal muscles of obese rats and the influence of long-term treatment with intranasal insulin. Translational medicine. 2015;(1):39-45.</mixed-citation><mixed-citation xml:lang="en">Kuznetsova LA, Derkach KV, Sharova TS, et al. The activity of no-synthases in the brain, myocardium and skeletal muscles of obese rats and the influence of long-term treatment with intranasal insulin. Translational medicine. 2015;(1):39-45.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Derkach KV, Ignat’eva PA, Shpakov AO. Hormonal regulation of adenylyl cyclase in the myocardium of male rats with metabolic syndrome and the influence of treatment with metformin and intranasally administered insulin. Translational medicine. 2016;3(1):73-81. doi: 10.18705/2311-4495-2016-3-1-73-81</mixed-citation><mixed-citation xml:lang="en">Derkach KV, Ignat’eva PA, Shpakov AO. Hormonal regulation of adenylyl cyclase in the myocardium of male rats with metabolic syndrome and the influence of treatment with metformin and intranasally administered insulin. Translational medicine. 2016;3(1):73-81. doi: 10.18705/2311-4495-2016-3-1-73-81</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov AO. Functional activity of the brain insulin signaling system in norm and in type 2 diabetes mellitus. Russian journal of physiology. 2015;101(10):1103-1127.</mixed-citation><mixed-citation xml:lang="en">Shpakov AO. Functional activity of the brain insulin signaling system in norm and in type 2 diabetes mellitus. Russian journal of physiology. 2015;101(10):1103-1127.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov AO, Derkach KV. The Melanocortin Signal System of the Hypothalamus and Its Functional State in Type 2 Diabetes Mellitus and Metabolic Syndrome. Russian journal of physiology. 2017;103(5):504-517.</mixed-citation><mixed-citation xml:lang="en">Shpakov AO, Derkach KV. The Melanocortin Signal System of the Hypothalamus and Its Functional State in Type 2 Diabetes Mellitus and Metabolic Syndrome. Russian journal of physiology. 2017;103(5):504-517.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Sukhov IB, Shipilov VN, Chistyakova OV, et al. Long-term intranasal insulin administration improves spatial memory in male rats with prolonged type 1 diabetes mellitus and in healthy rats. Dokl Akad Nauk. 2013;453(5):577. doi: 10.7868/S0869565213350272</mixed-citation><mixed-citation xml:lang="en">Sukhov IB, Shipilov VN, Chistyakova OV, et al. Long-term intranasal insulin administration improves spatial memory in male rats with prolonged type 1 diabetes mellitus and in healthy rats. Dokl Akad Nauk. 2013;453(5):577. doi: 10.7868/S0869565213350272</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Derkach KV, Bogush IV, Berstein LM, Shpakov AO. The Influence of Intranasal Insulin on Hypothalamic-Pituitary-Thyroid Axis in Normal and Diabetic Rats. Horm Metab Res. 2015;47(12):916-924. doi: https://doi.org/10.1055/s-0035-1547236</mixed-citation><mixed-citation xml:lang="en">Derkach KV, Bogush IV, Berstein LM, Shpakov AO. The Influence of Intranasal Insulin on Hypothalamic-Pituitary-Thyroid Axis in Normal and Diabetic Rats. Horm Metab Res. 2015;47(12):916-924. doi: https://doi.org/10.1055/s-0035-1547236</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
